Association of Prophylactic Antibiotics With Early Infectious Complications in Children With Cancer Undergoing Central Venous Access Device Placement

Ann SurgPublished Retrospective cohort study

Main finding · Early infectious complications, overallResult — go to the resultOdds ratio 0.55 95% CI 0.39–0.79

Authors' conclusion

Prophylactic antibiotics are associated with reduced early infectious complications after central VAD placement overall.

Study context

Population
Children with cancer undergoing central venous access device (VAD) placement, Pediatric Health Information System database, 2017–20216,058 ports · 3,158 tunneled lines
Participants
9,216 children
Exposure
Prophylactic antibiotics vs none at central VAD placement
Outcome
Early infectious complications:
  • Surgical site infections
  • Central line-associated bloodstream infections
  • Bacteremia
Methodological detailsmultivariable logistic regression, Pediatric Health Information System database
  • Multivariable logistic regression
  • Pediatric Health Information System database

Main finding

Early infectious complications, overall

Odds ratio

0.55

95% CI 0.39–0.79

P < 0.001

By group

Prophylactic antibiotics vs No prophylactic antibiotics
OR 0.55 (95% CI 0.39–0.79); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
Early infectious complications, tunneled lines (subgroup)0.59 (0.41–0.84)
Early infectious complications, ports (subgroup)3.01 (0.66–13.78)

Factors associated with early infection (multivariate analysis)

Prophylactic antibiotics, OR
0.67 (95% CI 0.45-0.97)
Solid tumors, OR
0.38 (95% CI 0.22-0.64)
Tunneled lines, OR
20.78 (95% CI 9.83-43.93)
Acute myelogenous leukemia, OR
2.37 (95% CI 1.58-3.57)

Original publication

Association of Prophylactic Antibiotics With Early Infectious Complications in Children With Cancer Undergoing Central Venous Access Device Placement. Ann Surg. Published 23 October 2023. doi:10.1097/sla.0000000000006140

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.